Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Drug detection dogs at Australian outdoor music festivals: Deterrent, detection and iatrogenic effects.

Grigg J, Barratt MJ, Lenton S.

Int J Drug Policy. 2018 Aug 31;60:89-95. doi: 10.1016/j.drugpo.2018.08.002. [Epub ahead of print]

PMID:
30176423
2.

Digital era drug surveillance: Quo vadis, Australia?

Raubenheimer JE, Barratt MJ.

Drug Alcohol Rev. 2018 Sep;37(6):693-696. doi: 10.1111/dar.12853. No abstract available.

PMID:
30175478
3.

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold hopping analogue of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Banister SD, Adams A, Kevin RC, Macdonald C, Glass M, Boyd R, Connor M, McGregor IS, Havel CM, Bright SJ, Ventura M, Gil C, Barratt MJ, Gerona RR.

Drug Test Anal. 2018 Aug 27. doi: 10.1002/dta.2491. [Epub ahead of print]

PMID:
30151911
4.

Typology of new psychoactive substance use among the general Australian population.

Sutherland R, Peacock A, Roxburgh A, Barratt MJ, Burns L, Bruno R.

Drug Alcohol Depend. 2018 Jul 1;188:126-134. doi: 10.1016/j.drugalcdep.2018.03.034. Epub 2018 May 3.

PMID:
29775956
5.

The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.

Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J.

Int J Drug Policy. 2018 Jun;56:162-175. doi: 10.1016/j.drugpo.2018.03.032. Epub 2018 May 3.

PMID:
29731288
6.

Drug-related police encounters across the globe: How do they compare?

Hughes CE, Barratt MJ, Ferris JA, Maier LJ, Winstock AR.

Int J Drug Policy. 2018 Jun;56:197-207. doi: 10.1016/j.drugpo.2018.03.005. Epub 2018 Apr 24.

PMID:
29699837
7.

Do people with intersecting identities report more high-risk alcohol use and lifetime substance use?

Demant D, Oviedo-Trespalacios O, Carroll JA, Ferris JA, Maier L, Barratt MJ, Winstock AR.

Int J Public Health. 2018 Jun;63(5):621-630. doi: 10.1007/s00038-018-1095-5. Epub 2018 Mar 31.

PMID:
29605878
8.

Author Correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.

Lawn W, Hallak JE, Crippa JA, Dos Santos R, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA.

Sci Rep. 2018 Mar 1;8(1):4059. doi: 10.1038/s41598-018-21666-6.

9.

Harms, benefits and the policing of cryptomarkets: a response to commentaries.

Aldridge J, Stevens A, Barratt MJ.

Addiction. 2018 May;113(5):802-804. doi: 10.1111/add.14169. Epub 2018 Feb 21. No abstract available.

PMID:
29468766
10.

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.

Lawn W, Hallak JE, Crippa JA, Dos Santos R, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA.

Sci Rep. 2017 Nov 9;7(1):15201. doi: 10.1038/s41598-017-14700-6. Erratum in: Sci Rep. 2018 Mar 1;8(1):4059.

11.

Exploring mortality among drug treatment clients: The relationship between treatment type and mortality.

Lloyd B, Zahnow R, Barratt MJ, Best D, Lubman DI, Ferris J.

J Subst Abuse Treat. 2017 Nov;82:22-28. doi: 10.1016/j.jsat.2017.09.001. Epub 2017 Sep 5.

PMID:
29021111
12.

Moving on From Representativeness: Testing the Utility of the Global Drug Survey.

Barratt MJ, Ferris JA, Zahnow R, Palamar JJ, Maier LJ, Winstock AR.

Subst Abuse. 2017 Jun 30;11:1178221817716391. doi: 10.1177/1178221817716391. eCollection 2017.

13.

Synthetic Cannabinoid Use Among High School Seniors.

Palamar JJ, Barratt MJ, Coney L, Martins SS.

Pediatrics. 2017 Oct;140(4). pii: e20171330. doi: 10.1542/peds.2017-1330. Epub 2017 Sep 11.

PMID:
28893851
14.

Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunction.

Mahfuz M, Das S, Mazumder RN, Masudur Rahman M, Haque R, Bhuiyan MMR, Akhter H, Sarker MSA, Mondal D, Muaz SSA, Karim ASMB, Borowitz SM, Moskaluk CA, Barratt MJ, Petri WA, Gordon JI, Ahmed T.

BMJ Open. 2017 Aug 11;7(8):e017768. doi: 10.1136/bmjopen-2017-017768.

15.

The Gut Microbiota, Food Science, and Human Nutrition: A Timely Marriage.

Barratt MJ, Lebrilla C, Shapiro HY, Gordon JI.

Cell Host Microbe. 2017 Aug 9;22(2):134-141. doi: 10.1016/j.chom.2017.07.006. Review.

16.

Will growth in cryptomarket drug buying increase the harms of illicit drugs?

Aldridge J, Stevens A, Barratt MJ.

Addiction. 2018 May;113(5):789-796. doi: 10.1111/add.13899. Epub 2017 Aug 2.

17.

Food and microbiota in the FDA regulatory framework.

Green JM, Barratt MJ, Kinch M, Gordon JI.

Science. 2017 Jul 7;357(6346):39-40. doi: 10.1126/science.aan0836. No abstract available.

18.

The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal's Boom Festival.

Martins D, Barratt MJ, Pires CV, Carvalho H, Vilamala MV, Espinosa IF, Valente H.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2608. Epub 2017 Jun 21.

PMID:
28635119
19.

Pill testing or drug checking in Australia: Acceptability of service design features.

Barratt MJ, Bruno R, Ezard N, Ritter A.

Drug Alcohol Rev. 2018 Feb;37(2):226-236. doi: 10.1111/dar.12576. Epub 2017 Jun 20.

PMID:
28635057
20.

The utility of drug checking services as monitoring tools and more: A response to Pirona et al.

Giné CV, Vilamala MV, Measham F, Brunt TM, Bücheli A, Paulos C, Valente H, Martins D, Libois B, Tögel-Lins K, Jones G, Karden A, Barratt MJ.

Int J Drug Policy. 2017 Jul;45:46-47. doi: 10.1016/j.drugpo.2017.05.018. Epub 2017 Jun 2. No abstract available.

PMID:
28582668
21.

Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Lamy FR, Daniulaityte R, Nahhas RW, Barratt MJ, Smith AG, Sheth A, Martins SS, Boyer EW, Carlson RG.

Int J Drug Policy. 2017 Jun;44:121-129. doi: 10.1016/j.drugpo.2017.05.007. Epub 2017 Jun 1.

22.

Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.

Coney LD, Maier LJ, Ferris JA, Winstock AR, Barratt MJ.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2599. Epub 2017 May 18.

PMID:
28517366
23.

New psychoactive substances: Purchasing and supply patterns in Australia.

Sutherland R, Bruno R, Peacock A, Dietze P, Breen C, Burns L, Barratt MJ.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2577. Epub 2017 May 18.

PMID:
28517235
24.

The effects of micronutrient deficiencies on bacterial species from the human gut microbiota.

Hibberd MC, Wu M, Rodionov DA, Li X, Cheng J, Griffin NW, Barratt MJ, Giannone RJ, Hettich RL, Osterman AL, Gordon JI.

Sci Transl Med. 2017 May 17;9(390). pii: eaal4069. doi: 10.1126/scitranslmed.aal4069.

25.

Motivations for new psychoactive substance use among regular psychostimulant users in Australia.

Sutherland R, Bruno R, Peacock A, Lenton S, Matthews A, Salom C, Dietze P, Butler K, Burns L, Barratt MJ.

Int J Drug Policy. 2017 May;43:23-32. doi: 10.1016/j.drugpo.2016.12.021. Epub 2017 Feb 2.

PMID:
28161577
26.

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Anderson LS, Bell HG, Gilbert M, Davidson JE, Winter C, Barratt MJ, Win B, Painter JL, Menone C, Sayegh J, Dasgupta N.

JMIR Public Health Surveill. 2017 Feb 1;3(1):e6. doi: 10.2196/publichealth.6174.

27.

Commentary on Vrolijk et al. (2017): The paradox of the quality control problem.

Barratt MJ, Ritter A.

Addiction. 2017 Jan;112(1):101-102. doi: 10.1111/add.13611. No abstract available.

PMID:
27936508
28.

A critical examination of the definition of 'psychoactive effect' in Australian drug legislation.

Barratt MJ, Seear K, Lancaster K.

Int J Drug Policy. 2017 Feb;40:16-25. doi: 10.1016/j.drugpo.2016.10.002. Epub 2016 Nov 21.

PMID:
27884504
29.

Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask).

Barratt MJ, Aldridge J.

Int J Drug Policy. 2016 Sep;35:1-6. doi: 10.1016/j.drugpo.2016.07.005. Epub 2016 Jul 25. No abstract available.

PMID:
27523571
30.

Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.

Palamar JJ, Barratt MJ, Ferris JA, Winstock AR.

Am J Addict. 2016 Aug;25(5):400-7. doi: 10.1111/ajad.12403. Epub 2016 Jul 15.

31.

Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics.

Blanton LV, Barratt MJ, Charbonneau MR, Ahmed T, Gordon JI.

Science. 2016 Jun 24;352(6293):1533. doi: 10.1126/science.aad9359. Review.

PMID:
27339978
32.

Safer scoring? Cryptomarkets, social supply and drug market violence.

Barratt MJ, Ferris JA, Winstock AR.

Int J Drug Policy. 2016 Sep;35:24-31. doi: 10.1016/j.drugpo.2016.04.019. Epub 2016 May 6.

PMID:
27241015
33.

Results of an international drug testing service for cryptomarket users.

Caudevilla F, Ventura M, Fornís I, Barratt MJ, Vidal C, Lladanosa CG, Quintana P, Muñoz A, Calzada N.

Int J Drug Policy. 2016 Sep;35:38-41. doi: 10.1016/j.drugpo.2016.04.017. Epub 2016 May 6.

PMID:
27239011
34.

'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.

Barratt MJ, Lenton S, Maddox A, Allen M.

Int J Drug Policy. 2016 Sep;35:50-7. doi: 10.1016/j.drugpo.2016.04.006. Epub 2016 Apr 13.

PMID:
27157539
35.

Synthetic cannabinoids: undesirable alternatives to natural marijuana.

Palamar JJ, Barratt MJ.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):371-3. doi: 10.3109/00952990.2016.1139584. Epub 2016 Apr 11. No abstract available.

36.

Drug checking to improve monitoring of new psychoactive substances in Australia.

Butterfield RJ, Barratt MJ, Ezard N, Day RO.

Med J Aust. 2016 Mar 7;204(4):144-5. No abstract available.

PMID:
26937663
37.

Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children.

Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, Subramanian S, Manary MJ, Trehan I, Jorgensen JM, Fan YM, Henrissat B, Leyn SA, Rodionov DA, Osterman AL, Maleta KM, Newgard CB, Ashorn P, Dewey KG, Gordon JI.

Science. 2016 Feb 19;351(6275). pii: aad3311. doi: 10.1126/science.aad3311.

38.

Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition.

Charbonneau MR, O'Donnell D, Blanton LV, Totten SM, Davis JC, Barratt MJ, Cheng J, Guruge J, Talcott M, Bain JR, Muehlbauer MJ, Ilkayeva O, Wu C, Struckmeyer T, Barile D, Mangani C, Jorgensen J, Fan YM, Maleta K, Dewey KG, Ashorn P, Newgard CB, Lebrilla C, Mills DA, Gordon JI.

Cell. 2016 Feb 25;164(5):859-71. doi: 10.1016/j.cell.2016.01.024. Epub 2016 Feb 18.

39.

Drug checking interventions can track the nature and size of the discrepancy between self-report and actual drugs consumed.

Barratt MJ, Ezard N.

Addiction. 2016 Mar;111(3):558-9. doi: 10.1111/add.13194. Epub 2015 Dec 21. No abstract available.

PMID:
26687242
40.

Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.

Potter GR, Barratt MJ, Malm A, Bouchard M, Blok T, Christensen AS, Decorte T, Frank VA, Hakkarainen P, Klein A, Lenton S, Perälä J, Werse B, Wouters M.

Int J Drug Policy. 2015 Mar;26(3):226-37. doi: 10.1016/j.drugpo.2014.12.007. Epub 2014 Dec 16.

PMID:
25582281
41.

Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.

Barratt MJ, Potter GR, Wouters M, Wilkins C, Werse B, Perälä J, Pedersen MM, Nguyen H, Malm A, Lenton S, Korf D, Klein A, Heyde J, Hakkarainen P, Frank VA, Decorte T, Bouchard M, Blok T.

Int J Drug Policy. 2015 Mar;26(3):238-49. doi: 10.1016/j.drugpo.2014.12.004. Epub 2014 Dec 13.

PMID:
25576247
42.

Representativeness of online purposive sampling with Australian cannabis cultivators.

Barratt MJ, Lenton S.

Int J Drug Policy. 2015 Mar;26(3):323-6. doi: 10.1016/j.drugpo.2014.10.007. Epub 2014 Nov 4. No abstract available.

PMID:
25433986
43.

Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.

Lenton S, Frank VA, Barratt MJ, Dahl HV, Potter GR.

Int J Drug Policy. 2015 Mar;26(3):257-66. doi: 10.1016/j.drugpo.2014.08.002. Epub 2014 Aug 18.

PMID:
25181993
44.

Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.

Hakkarainen P, Frank VA, Barratt MJ, Dahl HV, Decorte T, Karjalainen K, Lenton S, Potter G, Werse B.

Int J Drug Policy. 2015 Mar;26(3):250-6. doi: 10.1016/j.drugpo.2014.07.005. Epub 2014 Jul 21.

PMID:
25123694
45.

Persistent gut microbiota immaturity in malnourished Bangladeshi children.

Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, Benezra A, DeStefano J, Meier MF, Muegge BD, Barratt MJ, VanArendonk LG, Zhang Q, Province MA, Petri WA Jr, Ahmed T, Gordon JI.

Nature. 2014 Jun 19;510(7505):417-21. doi: 10.1038/nature13421. Epub 2014 Jun 4.

46.

"PMA sounds fun": negotiating drug discourses online.

Barratt MJ, Allen M, Lenton S.

Subst Use Misuse. 2014 Jun;49(8):987-98. doi: 10.3109/10826084.2013.852584.

PMID:
24779498
47.

Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States.

Barratt MJ, Ferris JA, Winstock AR.

Addiction. 2014 May;109(5):774-83. doi: 10.1111/add.12470. Epub 2014 Feb 12.

PMID:
24372954
48.

NBOMe - a very different kettle of fish . . .

Caldicott DG, Bright SJ, Barratt MJ.

Med J Aust. 2013 Sep 2;199(5):322-3. No abstract available.

PMID:
23992179
49.
50.

Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views.

Chiauzzi E, Dasmahapatra P, Lobo K, Barratt MJ.

Subst Use Misuse. 2013 Jun;48(8):661-70. doi: 10.3109/10826084.2013.800117. Epub 2013 Jun 10.

PMID:
23750771

Supplemental Content

Loading ...
Support Center